Aarti Drugs Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA4453440
EBIT3952940
Earning Per Share302218
Expenses1,7182,1592,410
Net Profit280205166
Net Profit Margin1386
Operating Profit Margin201411
Profit Before Tax369270224
Dividends Per Share310
Operation Revenue2,1592,5002,718

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Aarti Drugs is 0 as of 10/2/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20092009200920092023
Operating Activities65656565134
Investing Activities-12-12-12-12-164
Financing Activities-54-54-54-5417
Others00000
Net Cash Flow-1-1-1-1-13

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Aarti Drugs is 134 as of 10/2/2023